Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Merck Serono Will Cut Jobs, Close Facility

by Lisa M. Jarvis
April 30, 2012 | A version of this story appeared in Volume 90, Issue 18

Merck KGaA is cutting 500 jobs from its pharmaceuticals arm, Merck Serono, as part of a corporate overhaul. Merck Serono’s headquarters in Geneva will be closed, and operations will be transferred to Merck’s Darmstadt, Germany, base. Of the 1,250 jobs in Geneva, some 750 will be moved to other sites by the second half of 2013. R&D positions will be transferred to Darmstadt, Boston, and Beijing. The German firm cites market shifts, increasing competition, and corporate inefficiencies as driving the restructuring. Merck Serono says it will commit up to $40 million in funding to support the spin-off of compounds or other activities that no longer fit its core business.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.